造影剤注入システム市場：製品タイプ別（消耗品、注入システム、付属品）、用途別（放射線学、介入放射線学、介入心臓学）、エンドユーザー別（病院、診断センター、診療所、その他）。世界の機会分析および産業予測、2020-2030年

Contrast Injector Systems Market By Product Type (Consumables, Injector Systems, Accessories), By Application (Radiology, Interventional Radiology, Interventional Cardiology), By End User (Hospitals, Diagnostics centers, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

造影剤注入装置は、体液、組織、骨、静脈、動脈などの体内構造物の視認性を高め、病気の診断に役立てるための装置である。このシステムは、造影剤を利用して、体内構造の画像化を向上させる。CT（コンピュータ断... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,939 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	120	英語

サマリー

造影剤注入装置は、体液、組織、骨、静脈、動脈などの体内構造物の視認性を高め、病気の診断に役立てるための装置である。このシステムは、造影剤を利用して、体内構造の画像化を向上させる。CT（コンピュータ断層撮影）、MRI（磁気共鳴画像装置）、血管造影などの画像診断により、さまざまな病態を可視化することができます。これらの装置は、がん、アルツハイマー病、認知症など、さまざまな慢性疾患の治療に広く使用されています。例えば、血管や胃腸管の視認性を向上させるために使用されています。
造影剤注入システムの世界市場の成長を促進する主な要因としては、血管造影、コンピュータ断層撮影、磁気共鳴画像法など、造影剤を用いた医療用画像処理プロセスの急速な普及が挙げられます。また、高齢者人口の増加や慢性疾患の蔓延も、市場の成長を後押ししています。しかし、造影剤注入システムに関連する高コストや注入システムおよび造影剤に関連するリスクは、市場の成長を制限すると予想されます。
造影剤注入システム市場は、製品タイプ、アプリケーション、エンドユーザー、地域によって区分されます。製品タイプ別に見ると、市場はインジェクターシステム、消耗品、アクセサリーに分類されます。アプリケーション別では、インターベンショナルラジオロジー、インターベンショナルカーディオロジー、ラジオロジーに区分されます。エンドユーザー別では、診断センター、診療所、病院、その他に分かれます。地域別では、北米、欧州、アジア太平洋、LAMEA)にわたって分析されています。
本レポートで紹介する主な企業は、Bracco Imaging S.p.A、Bayer HealthCare、Guerbet Group、Medtron AG、Ulrich GmbH & Co.KG、GEヘルスケア、Shenzhen Seacrown Electromechanical Co.Ltd.、Sino Medical- Device Technology Co., Ltd.、Vivid Imagingの6社です。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Consumables
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Injector Systems
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Accessories
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Radiology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Interventional Radiology
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Interventional Cardiology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: CONTRAST INJECTOR SYSTEMS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Diagnostics centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Clinics
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: CONTRAST INJECTOR SYSTEMS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Bracco Imaging S.p.A
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 bayer healthcare
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Guerbet Group
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Medtron AG
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Ulrich GmbH & Co. KG
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 GE Healthcare
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Shenzhen Seacrown Electromechanical Co., Ltd.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Nemoto Kyorindo Co. Ltd.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sino Medical- Device Technology Co., Ltd.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Vivid Imaging
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 2. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR CONSUMABLES, BY REGION , 2020-2030,($MILLION)
TABLE 3. CONTRAST INJECTOR SYSTEMS MARKET CONSUMABLES BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR INJECTOR SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 5. CONTRAST INJECTOR SYSTEMS MARKET INJECTOR SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR ACCESSORIES, BY REGION , 2020-2030,($MILLION)
TABLE 7. CONTRAST INJECTOR SYSTEMS MARKET ACCESSORIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 9. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR RADIOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 10. CONTRAST INJECTOR SYSTEMS MARKET RADIOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR INTERVENTIONAL RADIOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 12. CONTRAST INJECTOR SYSTEMS MARKET INTERVENTIONAL RADIOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR INTERVENTIONAL CARDIOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 14. CONTRAST INJECTOR SYSTEMS MARKET INTERVENTIONAL CARDIOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 16. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 17. CONTRAST INJECTOR SYSTEMS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR DIAGNOSTICS CENTERS, BY REGION , 2020-2030,($MILLION)
TABLE 19. CONTRAST INJECTOR SYSTEMS MARKET DIAGNOSTICS CENTERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 21. CONTRAST INJECTOR SYSTEMS MARKET CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. CONTRAST INJECTOR SYSTEMS MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 23. CONTRAST INJECTOR SYSTEMS MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. CONTRAST INJECTOR SYSTEMS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 25. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. U.S. CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 30. U.S. CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 31. U.S. CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 32. CANADA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 33. CANADA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 34. CANADA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 35. MEXICO CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 36. MEXICO CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 37. MEXICO CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 38. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 39. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 40. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 41. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 42. GERMANY CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 43. GERMANY CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 44. GERMANY CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 45. FRANCE CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 46. FRANCE CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 47. FRANCE CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 48. U.K. CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 49. U.K. CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 50. U.K. CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. ITALY CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 52. ITALY CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 53. ITALY CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 54. SPAIN CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 55. SPAIN CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 56. SPAIN CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 57. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 58. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 59. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 60. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 61. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 62. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 63. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 64. JAPAN CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 65. JAPAN CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 66. JAPAN CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 67. CHINA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 68. CHINA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 69. CHINA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 70. INDIA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 71. INDIA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 72. INDIA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 73. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 74. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 75. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 76. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 77. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 78. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 79. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 80. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 81. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 82. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 83. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 84. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 85. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 86. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 87. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 88. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 89. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 90. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 91. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 92. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 93. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 94. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET BY END USER 2020-2030,($MILLION)
TABLE 95.BRACCO IMAGING S.P.A: COMPANY SNAPSHOT
TABLE 96.BRACCO IMAGING S.P.A: OPERATING SEGMENTS
TABLE 97.BRACCO IMAGING S.P.A: PRODUCT PORTFOLIO
TABLE 98.BRACCO IMAGING S.P.A: NET SALES,
TABLE 99.BRACCO IMAGING S.P.A: KEY STRATERGIES
TABLE 100.BAYER HEALTHCARE: COMPANY SNAPSHOT
TABLE 101.BAYER HEALTHCARE: OPERATING SEGMENTS
TABLE 102.BAYER HEALTHCARE: PRODUCT PORTFOLIO
TABLE 103.BAYER HEALTHCARE: NET SALES,
TABLE 104.BAYER HEALTHCARE: KEY STRATERGIES
TABLE 105.GUERBET GROUP: COMPANY SNAPSHOT
TABLE 106.GUERBET GROUP: OPERATING SEGMENTS
TABLE 107.GUERBET GROUP: PRODUCT PORTFOLIO
TABLE 108.GUERBET GROUP: NET SALES,
TABLE 109.GUERBET GROUP: KEY STRATERGIES
TABLE 110.MEDTRON AG: COMPANY SNAPSHOT
TABLE 111.MEDTRON AG: OPERATING SEGMENTS
TABLE 112.MEDTRON AG: PRODUCT PORTFOLIO
TABLE 113.MEDTRON AG: NET SALES,
TABLE 114.MEDTRON AG: KEY STRATERGIES
TABLE 115.ULRICH GMBH & CO. KG: COMPANY SNAPSHOT
TABLE 116.ULRICH GMBH & CO. KG: OPERATING SEGMENTS
TABLE 117.ULRICH GMBH & CO. KG: PRODUCT PORTFOLIO
TABLE 118.ULRICH GMBH & CO. KG: NET SALES,
TABLE 119.ULRICH GMBH & CO. KG: KEY STRATERGIES
TABLE 120.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 121.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 122.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 123.GE HEALTHCARE: NET SALES,
TABLE 124.GE HEALTHCARE: KEY STRATERGIES
TABLE 125.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 126.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: OPERATING SEGMENTS
TABLE 127.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 128.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: NET SALES,
TABLE 129.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: KEY STRATERGIES
TABLE 130.NEMOTO KYORINDO CO. LTD.: COMPANY SNAPSHOT
TABLE 131.NEMOTO KYORINDO CO. LTD.: OPERATING SEGMENTS
TABLE 132.NEMOTO KYORINDO CO. LTD.: PRODUCT PORTFOLIO
TABLE 133.NEMOTO KYORINDO CO. LTD.: NET SALES,
TABLE 134.NEMOTO KYORINDO CO. LTD.: KEY STRATERGIES
TABLE 135.SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 136.SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: OPERATING SEGMENTS
TABLE 137.SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
TABLE 138.SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: NET SALES,
TABLE 139.SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: KEY STRATERGIES
TABLE 140.VIVID IMAGING: COMPANY SNAPSHOT
TABLE 141.VIVID IMAGING: OPERATING SEGMENTS
TABLE 142.VIVID IMAGING: PRODUCT PORTFOLIO
TABLE 143.VIVID IMAGING: NET SALES,
TABLE 144.VIVID IMAGING: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.CONTRAST INJECTOR SYSTEMS MARKET SEGMENTATION
FIGURE 2.CONTRAST INJECTOR SYSTEMS MARKET,2020-2030
FIGURE 3.CONTRAST INJECTOR SYSTEMS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CONTRAST INJECTOR SYSTEMS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.CONTRAST INJECTOR SYSTEMS MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF INJECTOR SYSTEMS CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 15.CONTRAST INJECTOR SYSTEMS MARKET,BY APPLICATION,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF RADIOLOGY CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL RADIOLOGY CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL CARDIOLOGY CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 19.CONTRAST INJECTOR SYSTEMS MARKET,BY END USER,2020(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTICS CENTERS CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF CLINICS CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS CONTRAST INJECTOR SYSTEMS MARKET,2020-2030(%)
FIGURE 24.CONTRAST INJECTOR SYSTEMS MARKET BY REGION,2020
FIGURE 25.U.S. CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 26.CANADA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 27.MEXICO CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 28.GERMANY CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 29.FRANCE CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 30.U.K. CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 31.ITALY CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 32.SPAIN CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 33.REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 34.JAPAN CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 35.CHINA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 36.INDIA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 37.AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 38.REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 39.BRAZIL CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 40.SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 41.SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 42.REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET,2020-2030($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47.COMPETITIVE DASHBOARD
FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49.BRACCO IMAGING S.P.A.: NET SALES ,($MILLION)
FIGURE 50.BAYER HEALTHCARE.: NET SALES ,($MILLION)
FIGURE 51.GUERBET GROUP.: NET SALES ,($MILLION)
FIGURE 52.MEDTRON AG.: NET SALES ,($MILLION)
FIGURE 53.ULRICH GMBH & CO. KG.: NET SALES ,($MILLION)
FIGURE 54.GE HEALTHCARE.: NET SALES ,($MILLION)
FIGURE 55.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD..: NET SALES ,($MILLION)
FIGURE 56.NEMOTO KYORINDO CO. LTD..: NET SALES ,($MILLION)
FIGURE 57.SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD..: NET SALES ,($MILLION)
FIGURE 58.VIVID IMAGING.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

Contrast injector systems are devices that enhance the visibility of body structures, such as body fluids, tissues, bones, veins, and arteries for diagnosis of diseases. These systems utilize contrast media to improve imaging of body structures. The visualization of various pathologies is done through imaging procedures, such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. These devices are popularly used for the treatment of various chronic diseases, such as cancer, Alzheimer's, and dementia. For instance, it is used to improve the visibility of blood vessels and gastrointestinal tract.
The major factors that drive the growth of the global contrast injector systems market include, rapid use of medical imaging process through contrast injectors, such as angiography, computed tomography, and magnetic resonance imaging procedures. In addition, increase in geriatric population and high prevalence of chronic diseases globally, propel the market growth. However, high cost associated with contrast injector systems and risks related to injector systems and contrast media are expected to restrict the market growth.
The contrast injector systems market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is bifurcated, diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include, Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（消費財）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（accessories）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（消費財）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（accessories）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?